A recent review confirms the safety and efficacy of biosimilar insulins, addressing concerns and promoting their adoption for ...

AdventHealth researchers are seeking participants for a study that will attempt to identify people with type 1 diabetes early in their disease.

The study included 31,229 dementia-free adult United Kingdom Biobank participants aged 40 to 70 years. Exclusion criteria included chronic neurological disorders, insulin-dependent diabetes, and ...